Standard InChI: InChI=1S/C38H60O18/c1-16-11-37-9-5-20-35(2,7-4-8-36(20,3)34(50)55-32-29(49)26(46)23(43)18(13-40)52-32)21(37)6-10-38(16,15-37)56-33-30(27(47)24(44)19(14-41)53-33)54-31-28(48)25(45)22(42)17(12-39)51-31/h17-33,39-49H,1,4-15H2,2-3H3/t17-,18-,19-,20+,21+,22-,23-,24-,25+,26+,27+,28-,29-,30-,31+,32+,33+,35-,36-,37-,38+/m1/s1
Standard InChI Key: UEDUENGHJMELGK-HYDKPPNVSA-N
Associated Targets(Human)
Homo sapiens 32628 Activities
Activity Type
Relation
Activity value
Units
Action Type
Journal
PubMed Id
doi
Assay Aladdin ID
Raji 5516 Activities
Activity Type
Relation
Activity value
Units
Action Type
Journal
PubMed Id
doi
Assay Aladdin ID
Glucocorticoid receptor 14987 Activities
Activity Type
Relation
Activity value
Units
Action Type
Journal
PubMed Id
doi
Assay Aladdin ID
T1R1/T1R3 473 Activities
Activity Type
Relation
Activity value
Units
Action Type
Journal
PubMed Id
doi
Assay Aladdin ID
Associated Targets(non-human)
Human immunodeficiency virus type 1 reverse transcriptase 18245 Activities
Activity Type
Relation
Activity value
Units
Action Type
Journal
PubMed Id
doi
Assay Aladdin ID
Rattus norvegicus 775804 Activities
Activity Type
Relation
Activity value
Units
Action Type
Journal
PubMed Id
doi
Assay Aladdin ID
Mus musculus 284745 Activities
Activity Type
Relation
Activity value
Units
Action Type
Journal
PubMed Id
doi
Assay Aladdin ID
Plasmodium falciparum 966862 Activities
Activity Type
Relation
Activity value
Units
Action Type
Journal
PubMed Id
doi
Assay Aladdin ID
Candida albicans 78123 Activities
Activity Type
Relation
Activity value
Units
Action Type
Journal
PubMed Id
doi
Assay Aladdin ID
Cryptococcus neoformans 21258 Activities
Activity Type
Relation
Activity value
Units
Action Type
Journal
PubMed Id
doi
Assay Aladdin ID
Aspergillus fumigatus 16427 Activities
Activity Type
Relation
Activity value
Units
Action Type
Journal
PubMed Id
doi
Assay Aladdin ID
Staphylococcus aureus 210822 Activities
Activity Type
Relation
Activity value
Units
Action Type
Journal
PubMed Id
doi
Assay Aladdin ID
Escherichia coli 133304 Activities
Activity Type
Relation
Activity value
Units
Action Type
Journal
PubMed Id
doi
Assay Aladdin ID
Pseudomonas aeruginosa 123386 Activities
Activity Type
Relation
Activity value
Units
Action Type
Journal
PubMed Id
doi
Assay Aladdin ID
Mycobacterium intracellulare 1532 Activities
Activity Type
Relation
Activity value
Units
Action Type
Journal
PubMed Id
doi
Assay Aladdin ID
Syrian golden hamster 1610 Activities
Activity Type
Relation
Activity value
Units
Action Type
Journal
PubMed Id
doi
Assay Aladdin ID
Jejunum 1 Activities
Activity Type
Relation
Activity value
Units
Action Type
Journal
PubMed Id
doi
Assay Aladdin ID
Molecule Features
Natural Product: Yes
Oral: No
Chemical Probe: No
Parenteral: No
Molecule Type: Small molecule
Topical: No
First In Class: No
Black Box: No
Chirality: No
Availability: No
Prodrug: No
Drug Indications
MESH ID
MESH Heading
EFO IDs
EFO Terms
Max Phase for Indication
References
Mechanisms of Action
Mechanism of Action
Action Type
target ID
Target Name
Target Type
Target Organism
Binding Site Name
References
Properties
Molecular Weight: 804.88
Molecular Weight (Monoisotopic): 804.3780
AlogP: -2.94
#Rotatable Bonds: 9
Polar Surface Area: 294.98
Molecular Species: NEUTRAL
HBA: 18
HBD: 11
#RO5 Violations: 3
HBA (Lipinski): 18
HBD (Lipinski): 11
#RO5 Violations (Lipinski): 3
CX Acidic pKa: 11.84
CX Basic pKa:
CX LogP: -2.16
CX LogD: -2.16
Aromatic Rings: 0
Heavy Atoms: 56
QED Weighted: 0.06
Np Likeness Score: 1.88
References
1.DuBois GE, Dietrich PS, Lee JF, McGarraugh GV, Stephenson RA.. (1981) Diterpenoid sweeteners. Synthesis and sensory evaluation of stevioside analogues nondegradable to steviol., 24 (11):[PMID:7310801][10.1021/jm00143a001]
2.DuBois GE, Stephenson RA.. (1985) Diterpenoid sweeteners. Synthesis and sensory evaluation of stevioside analogues with improved organoleptic properties., 28 (1):[PMID:3965718][10.1021/jm00379a017]
3.Chang SF, Yang LM, Hsu FL, Hsu JY, Liaw JH, Lin SJ.. (2006) Transformation of steviol-16alpha,17-epoxide by Streptomyces griseus and Cunninghamella bainieri., 69 (10):[PMID:17067160][10.1021/np0602564]
4.Takasaki M, Konoshima T, Kozuka M, Tokuda H, Takayasu J, Nishino H, Miyakoshi M, Mizutani K, Lee KH.. (2009) Cancer preventive agents. Part 8: Chemopreventive effects of stevioside and related compounds., 17 (2):[PMID:19131254][10.1016/j.bmc.2008.11.077]
5.Akihisa T, Hamasaki Y, Tokuda H, Ukiya M, Kimura Y, Nishino H.. (2004) Microbial transformation of isosteviol and inhibitory effects on Epstein-Barr virus activation of the transformation products., 67 (3):[PMID:15043419][10.1021/np030393q]
7.Tan GT, Pezzuto JM, Kinghorn AD, Hughes SH.. (1991) Evaluation of natural products as inhibitors of human immunodeficiency virus type 1 (HIV-1) reverse transcriptase., 54 (1):[PMID:1710653][10.1021/np50073a012]
8.Ceunen S, Geuns JM.. (2013) Steviol glycosides: chemical diversity, metabolism, and function., 76 (6):[PMID:23713723][10.1021/np400203b]
9.Ibrahim MA, Rodenburg DL, Alves K, Fronczek FR, McChesney JD, Wu C, Nettles BJ, Venkataraman SK, Jaksch F.. (2014) Minor diterpene glycosides from the leaves of Stevia rebaudiana., 77 (5):[PMID:24758242][10.1021/np4009656]
10. (2008) T1R hetero-oligomeric taste receptors, cell lines that express said receptors, and taste compounds,
11.Wang M, Li H, Xu F, Gao X, Li J, Xu S, Zhang D, Wu X, Xu J, Hua H, Li D.. (2018) Diterpenoid lead stevioside and its hydrolysis products steviol and isosteviol: Biological activity and structural modification., 156 [PMID:30059803][10.1016/j.ejmech.2018.07.052]